These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 13039951)

  • 1. [Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants].
    FRANCESCON M; BUTTO M
    Acta Med Patav; 1952; 13(6):265-88. PubMed ID: 13039951
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type].
    TRONNBERG G
    Nord Med; 1955 Jun; 53(26):1028-9. PubMed ID: 13244879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 5. The control of prothrombin activity with tromexan therapy.
    WEINER M; SIMSON G; BURNS JJ; STEELE JM; BRODIE BB
    Am J Med; 1953 Jun; 14(6):689-93. PubMed ID: 13057878
    [No Abstract]   [Full Text] [Related]  

  • 6. [Control of dicoumarin effect on blood coagulation].
    THIES HA
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1952-1953; 273():320-2. PubMed ID: 13045631
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
    SERT AS
    Tip Fak Mecm; 1954; 17(3):434-9. PubMed ID: 13226361
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with coumarin anticoagulants warfarin and warfarin sodium.
    CLATANOFF DV; TRIGGS PO; MEYER OO
    AMA Arch Intern Med; 1954 Aug; 94(2):213-20. PubMed ID: 13180041
    [No Abstract]   [Full Text] [Related]  

  • 9. The laboratory control of anticoagulant therapy; factors determining the accuracy of one-stage prothrombin time determinations.
    BLANCHARD EW
    Am J Med Technol; 1953; 19(4):182-97. PubMed ID: 13065309
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.
    MAYER GA; CONNELL WF
    J Am Med Assoc; 1956 Jun; 161(9):806-11. PubMed ID: 13319011
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of hematic fibrinogen during treatment with marcoumar and with marcoumar and vitamin K; clinical and experimental aspects].
    RICCI M
    Arch Sci Med (Torino); 1955 Feb; 99(2):112-29. PubMed ID: 13259907
    [No Abstract]   [Full Text] [Related]  

  • 12. [STATUS OF THE BLOOD COAGULATION SYSTEM AND THE USE OF ANTICOAGULANTS IN PATIENTS WITH STRANGULATED HERNIA].
    PAVLOVSKII DP
    Khirurgiia (Mosk); 1964 Feb; 40():145-52. PubMed ID: 14170172
    [No Abstract]   [Full Text] [Related]  

  • 13. [The fibrinogenemia of the newborn].
    SALAZAR DE SOUSA C; CRESPO FERREIRA J; FERREIRA GOMES A; ESTRELA A
    Arch Fr Pediatr; 1953; 10(5):474-9. PubMed ID: 13081188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
    JURGENS R
    Schweiz Med Wochenschr; 1953 May; 83(20):471-5. PubMed ID: 13076081
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
    COTTON RC; WADE EG
    Clin Sci; 1964 Apr; 26():337-43. PubMed ID: 14162427
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 17. Prothrombin and haemorrhage.
    DONALD AC; HUNTER RB; TUDHOPE GR; WALKER W; WHITTON I
    Br Med J; 1954 Oct; 2(4894):961-3. PubMed ID: 13199356
    [No Abstract]   [Full Text] [Related]  

  • 18. [METHOD OF SIMULTANEOUS DETERMINATION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS].
    GRIBAUSKAS PS
    Lab Delo; 1964; 10():3-5. PubMed ID: 14138437
    [No Abstract]   [Full Text] [Related]  

  • 19. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 20. THE EFFECT OF ATROMID ON PLASMA FIBRINOGEN AND HEPARIN RESISTANCE.
    COTTON RC; WADE EG; SPILLER GW
    J Atheroscler Res; 1963; 3():648-52. PubMed ID: 14100908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.